Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987

Gespeichert in:
Bibliographische Detailangaben
Format: Tagungsbericht Buch
Sprache:English
Veröffentlicht: London [u.a.] Acad. Press 1988
Schriftenreihe:Cancer treatment reviews Supplement ; 15,A
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV001220995
003 DE-604
005 20021108
007 t|
008 890315s1988 xx ad|| |||| 10||| eng d
035 |a (OCoLC)17812759 
035 |a (DE-599)BVBBV001220995 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-19 
050 0 |a RC271.I46 
245 1 0 |a Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies  |b proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987  |c ed. K. Hellmann 
264 1 |a London [u.a.]  |b Acad. Press  |c 1988 
300 |a 65 S.  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Cancer treatment reviews : Supplement  |v 15,A 
650 4 |a Interferon Type I  |x therapeutic use  |v Congresses 
650 4 |a Interferon  |x Therapeutic use  |v Congresses 
650 4 |a Leukemia  |x Treatment  |v Congresses 
650 4 |a Leukemia  |x therapy  |v Congresses 
650 4 |a Lymphoma, Non-Hodgkin  |x therapy  |v Congresses 
650 4 |a Lymphomas  |x Treatment  |v Congresses 
650 4 |a Multiple Myeloma  |x therapy  |v Congresses 
650 4 |a Multiple myeloma  |x Treatment  |v Congresses 
655 7 |0 (DE-588)1071861417  |a Konferenzschrift  |2 gnd-content 
700 1 |a Hellmann, Kurt  |e Sonstige  |4 oth 
711 2 |a Satellite Symposium on Intron A  |d 1987  |c Lugano  |j Sonstige  |0 (DE-588)1217043-4  |4 oth 
711 2 |a International Conference on Malignant Lymphoma  |n 3  |d 1987  |c Lugano  |j Sonstige  |0 (DE-588)1217042-2  |4 oth 
830 0 |a Cancer treatment reviews  |v Supplement ; 15,A  |w (DE-604)BV000900546  |9 15,A 
943 1 |a oai:aleph.bib-bvb.de:BVB01-000736414 

Datensatz im Suchindex

DE-19_call_number 0760/8 Med.GZ 579(15
DE-19_location 55
DE-BY-UBM_katkey 445884
DE-BY-UBM_local_keycode ko
DE-BY-UBM_media_number 9999419673
_version_ 1823049956855906304
any_adam_object
building Verbundindex
bvnumber BV001220995
callnumber-first R - Medicine
callnumber-label RC271
callnumber-raw RC271.I46
callnumber-search RC271.I46
callnumber-sort RC 3271 I46
callnumber-subject RC - Internal Medicine
ctrlnum (OCoLC)17812759
(DE-599)BVBBV001220995
format Conference Proceeding
Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01751nam a2200409 cb4500</leader><controlfield tag="001">BV001220995</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20021108 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">890315s1988 xx ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)17812759</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001220995</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.I46</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies</subfield><subfield code="b">proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987</subfield><subfield code="c">ed. K. Hellmann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">65 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer treatment reviews : Supplement</subfield><subfield code="v">15,A</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon Type I</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon</subfield><subfield code="x">Therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leukemia</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leukemia</subfield><subfield code="x">therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphoma, Non-Hodgkin</subfield><subfield code="x">therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lymphomas</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple Myeloma</subfield><subfield code="x">therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple myeloma</subfield><subfield code="x">Treatment</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hellmann, Kurt</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Satellite Symposium on Intron A</subfield><subfield code="d">1987</subfield><subfield code="c">Lugano</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)1217043-4</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">International Conference on Malignant Lymphoma</subfield><subfield code="n">3</subfield><subfield code="d">1987</subfield><subfield code="c">Lugano</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)1217042-2</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer treatment reviews</subfield><subfield code="v">Supplement ; 15,A</subfield><subfield code="w">(DE-604)BV000900546</subfield><subfield code="9">15,A</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000736414</subfield></datafield></record></collection>
genre (DE-588)1071861417 Konferenzschrift gnd-content
genre_facet Konferenzschrift
id DE-604.BV001220995
illustrated Illustrated
indexdate 2025-02-03T16:12:11Z
institution BVB
institution_GND (DE-588)1217043-4
(DE-588)1217042-2
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-000736414
oclc_num 17812759
open_access_boolean
owner DE-19
DE-BY-UBM
owner_facet DE-19
DE-BY-UBM
physical 65 S. Ill., graph. Darst.
publishDate 1988
publishDateSearch 1988
publishDateSort 1988
publisher Acad. Press
record_format marc
series Cancer treatment reviews
series2 Cancer treatment reviews : Supplement
spellingShingle Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987
Cancer treatment reviews
Interferon Type I therapeutic use Congresses
Interferon Therapeutic use Congresses
Leukemia Treatment Congresses
Leukemia therapy Congresses
Lymphoma, Non-Hodgkin therapy Congresses
Lymphomas Treatment Congresses
Multiple Myeloma therapy Congresses
Multiple myeloma Treatment Congresses
subject_GND (DE-588)1071861417
title Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987
title_auth Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987
title_exact_search Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987
title_full Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987 ed. K. Hellmann
title_fullStr Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987 ed. K. Hellmann
title_full_unstemmed Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987 ed. K. Hellmann
title_short Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies
title_sort strategies for the integration of intron a interferon alfa 2b into the treatment of hematological malignancies proceedings of a satellite symposium on intron a at the third international conference on malignant lymphoma lugano june 1987
title_sub proceedings of a Satellite Symposium on Intron A at the Third International Conference on Malignant Lymphoma, Lugano, June 1987
topic Interferon Type I therapeutic use Congresses
Interferon Therapeutic use Congresses
Leukemia Treatment Congresses
Leukemia therapy Congresses
Lymphoma, Non-Hodgkin therapy Congresses
Lymphomas Treatment Congresses
Multiple Myeloma therapy Congresses
Multiple myeloma Treatment Congresses
topic_facet Interferon Type I therapeutic use Congresses
Interferon Therapeutic use Congresses
Leukemia Treatment Congresses
Leukemia therapy Congresses
Lymphoma, Non-Hodgkin therapy Congresses
Lymphomas Treatment Congresses
Multiple Myeloma therapy Congresses
Multiple myeloma Treatment Congresses
Konferenzschrift
volume_link (DE-604)BV000900546
work_keys_str_mv AT hellmannkurt strategiesfortheintegrationofintronainterferonalfa2bintothetreatmentofhematologicalmalignanciesproceedingsofasatellitesymposiumonintronaatthethirdinternationalconferenceonmalignantlymphomaluganojune1987
AT satellitesymposiumonintronalugano strategiesfortheintegrationofintronainterferonalfa2bintothetreatmentofhematologicalmalignanciesproceedingsofasatellitesymposiumonintronaatthethirdinternationalconferenceonmalignantlymphomaluganojune1987
AT internationalconferenceonmalignantlymphomalugano strategiesfortheintegrationofintronainterferonalfa2bintothetreatmentofhematologicalmalignanciesproceedingsofasatellitesymposiumonintronaatthethirdinternationalconferenceonmalignantlymphomaluganojune1987